Molecular analysis of streptogramin resistance in enterococci

International Journal of Medical Microbiology

Volumn 292, Issue 2, 2002, Pages 81-94

  Werner, Guido ^a   Klare, Ingo ^a   Witte, Wolfgang ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Enterococci; Erm(B); Quinupristin dalfopristin; Streptogramin resistance; Vat(D); Vat(E)

Indexed keywords

ENTEROCOCCUS FAECIUM;

ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN-DALFOPRISTIN; STREPTOGRAMIN DERIVATIVE; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DRUG COMBINATION; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; GENETICS; HUMAN; METABOLISM; REVIEW;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; STREPTOGRAMINS; VIRGINIAMYCIN;

EID: 0035992364     PISSN: 14384221     EISSN: None     Source Type: Journal    
DOI: 10.1078/1438-4221-00194     Document Type: Article

References (112)

1. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark
2. Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: Genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides
3. Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds
4. Comparative analysis of staphylococcal plasmids carrying three streptogramin-resistance genes: Vat-vgb-vga
5. Diversity among the Gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB
6. Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics
7. Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics
8. Nucleotide sequence of a staphylococcal plasmid gene, vgb, encoding a hydrolase inactivating the B compounds of virginiamycin-like antibiotics
9. Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics
10. Irreversible binding of pristinamycin IIA (streptogramin A) to ribosomes explains its "lasting damage" effect
11. RP59500: A proposed mechanism for its bacterial activity
12. Recent developments in streptogramin research
13. The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans
14. The streptogramin antibiotics: Update on their mechanism of action
15. In vitro and in vivo activity of quinupristin/dalfopristin
16. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin/dalfopristin against Enterococcus faecium
17. Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032
18. Diversity of structures carrying the high-level gentamicin resistance gene (aaco6-aph2) in Enterococcus faecalis strains isolated in France
19. RP59500 (quinupristin/dalfopristin): Three case reports of its use in infection due to Enterococcus faecium
20. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals of two states
21. In vivo transfer of the vanA gene cluster in the intestinal tract of germfree animals
22. In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds
23. The molecular basis of the inhibitory activities of type A and B synergimycins and related antibiotics on ribosomes
24. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes
25. Resistance to streptogramin antibiotics in Staphylococcus aureus
26. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci
27. Therapy with RP59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns
28. Indication of transposition of a mobile DNA element containing the vat(D) and erm(B) genes in Enterococcus faecium
29. Characterization of vancomycin-susceptible Enterococcus faecium isolates from humans, chickens, and pigs by ribo-printing and pulsed-field gel electrophoresis
30. Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals
31. Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains
32. satG, conferring resistance to streptogramin A, is widely distributed in Enterococcus faecium strains but not in staphylococci
33. Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds
34. First antibacterial for VREF
35. Fast and sensitive multiple sequence alignments on a microcomputer
36. A multi locus sequence typing scheme for Enterococcus faecium
37. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis
38. Horizontal transfer of the satA gene encoding streptogramin A resistance between isogenic Enterococcus faecium strains in the gastrointestinal tract of gnotobiotic rats
39. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in The Netherlands
40. Linkage of vat(E) and erm(B) in streptogramin-resistant Enterococcus faecium isolates from Europe
41. Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark
42. Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients
43. Antimicrobial activity of quinupristin/dalfopristin (RP 59500, Synercid®) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada
44. In vitro bactericidal activity alone and in combination against resistant strains of Enterococcus faecium and Staphylococcus aureus
45. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
46. Decreased incidence of VanA-type vancomycin-resistant enterococci isolates from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry
47. Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995
48. Streptogramins: An answer to antibiotic resistance in gram-positive bacteria
49. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci
50. Quinupristin/dalfopristin: A new therapeutic alternative for the treatment of vancomycin-resistant Enterococcus faecium and other serious gram-positive infections
51. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: Comparison with a control cohort
52. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers
53. Molecular analysis of naturally occurring ermC-encoding plasmids in staphylococci isolates from animals with and without previous contact to macrolide/lincosamide antibiotics
54. Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital
55. Quinupristin/dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience
56. Evidence of nosocomial infection in Japan caused by high-level gentamicin-resistant Enterococcus faecalis and identification of the pheromone-responsive plasmid encoding gentamicin resistance
57. Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAMβ1 results from deletion of 5′ leader peptide sequences
58. Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure
59. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus
60. Quinupristin/dalfopristin: Therapeutic potential for vancomycin-resistant enterococcal infections
61. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus
62. O-acetyltransferases for chloramphenicol and other natural products
63. Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969
64. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban
65. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: A prospective citywide survey
66. Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23S rRNA and the synergism of their inhibitory mechanisms
67. Macrolide resistance genes in Enterococcus spp.
68. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium
69. Nomenclature for macrolide-lincosamide-streptogramin B resistance determinants
70. From vanA Enterococcus hirae to vanA Enterococcus faecium: A study of feed supplementation with avoparcin and tylosin in young chickens
71. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin
72. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family
73. Safety and tolerability of quinupristin/dalfopristin: Administration guidelines
74. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers
75. Quinupristin/dalfopristin (RP59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: Case report
76. Resistance gene transfer in anaerobes: New insights, new problems
77. Prevalence of macrolide resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals
78. Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced sensitivity to glycopeptides
79. Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica
80. Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis
81. Variation within the vat(E) allele of Enterococcus faecium isolates from retail poultry samples
82. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin/dalfopristin
83. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility
84. Identification of vat(E-3), a novel gene encoding resistance to quinupristin-dalfopristin in a strain of Enterococcus faecium from a hospital patient in the United Kingdom
85. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe
86. Chapter 3 - Activity against enterococci
87. Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period
88. Antimicrobial resistance in pig samples from The Netherlands (five abattoirs) and Sweden
89. High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame?
90. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands
91. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin/dalfopristin
92. Inducible resistance to erythromycin in Staphylococcus aureus
93. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin
94. Structural alterations in the translational attenuator of constitutively expressed ermC genes
95. Molecular analysis of the translational attenuator of a constitutively expressed erm(A) gene from Staphylococcus intermedius
96. Methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides
97. Linkage of determinants for streptogramin A, macrolide-lincosamide-streptogramin B, and chloramphenicol resistance on a plasmid in Enterococcus faecium and dissemination of this cluster among streptogramin-resistant enterococci
98. The newly described msrC gene is not equally distributed among all isolates of Enterococcus faecium
99. Quinupristin/dalfopristin-resistant enterococci of the satA(vatD) and satG(vatE) genotypes from different ecological origins in Germany
100. Association between quinupristin/dalfopristin resistance in glycopeptide-resistant Enterococcus faecium and the use of additives in animal feed
101. Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium
102. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to streptogramin A compounds
103. Host specificity of vancomycin-resistant Enterococcus faecium
104. Comparative in vitro activity of quinupristin/dalfopristin against Enterococcus spp.
105. Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium
106. Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents
107. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
108. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus